يعرض 61 - 80 نتائج من 74,737 نتيجة بحث عن '(((( a non decrease ) OR ( 50 nn decrease ))) OR ( 5 ((nn decrease) OR (a decrease)) ))', وقت الاستعلام: 0.85s تنقيح النتائج
  1. 61

    Image_5_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg حسب Casey E. Vantucci (10528263)

    منشور في 2022
    "…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …"
  2. 62
  3. 63
  4. 64

    Spatial training decreases the association between Ndfip1 and Nedd4 and decreases endogenous Beclin 1 ubiquitination in the hippocampus. حسب Wei-Lun Hsu (1756123)

    منشور في 2023
    "…<p><b>(A)</b> The CA1 tissue lysates from non-trained and trained rats were immunoprecipitated with IgG and immunoblotted with anti-Nedd4 and anti-Ndfip1 antibodies to serve as the control group. …"
  5. 65
  6. 66
  7. 67

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs حسب Michael J. Cunningham (14267038)

    منشور في 2022
    "…Ariadne is a non-hallucinogenic analog in the phenylalkylamine chemical class of psychedelics that is closely related to an established synthetic hallucinogen, 2,5-dimethoxy-4-methyl-amphetamine (DOM), differing only by one methylene group in the α-position to the amine. …"
  8. 68

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs حسب Michael J. Cunningham (14267038)

    منشور في 2022
    "…Ariadne is a non-hallucinogenic analog in the phenylalkylamine chemical class of psychedelics that is closely related to an established synthetic hallucinogen, 2,5-dimethoxy-4-methyl-amphetamine (DOM), differing only by one methylene group in the α-position to the amine. …"
  9. 69
  10. 70
  11. 71
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77
  18. 78

    Table_1_Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.docx حسب Ha Young Jang (1522204)

    منشور في 2022
    "…The cancer risk showed a tendency to decrease rapidly when LTRAs were used in high dose (aHR = 0.56, 95% CI = 0.40–0.79) or for longer durations of more than 3 years (aHR = 0.68, 95% CI = 0.60–0.76) and 5 years (aHR = 0.33, 95% CI = 0.26–0.42). …"
  19. 79
  20. 80